Validity and reliability of the italian-Neonatal skin risk assessment scale (i-NSRAS)

Felice Curcio1, Manuel Vaquero Abellán2, Elisabetta Dioni3

  • 1Faculty of Medicine and Nursing, Department of Nursing, University of Córdoba, Córdoba, Spain; Faculty of Medicine and Surgery, University of Sassari (UNISS), Sassari, Italy.

PubMed

Insights

The Italian-Neonatal Skin Risk Assessment Scale is a valid and reliable tool for identifying infants at risk of pressure injuries. This newborn-specific scale aids in early intervention and resource management.

Area of Science:

  • Neonatal care
  • Dermatology
  • Clinical assessment tools

Background:

  • Infant skin possesses unique anatomical and physiological characteristics, increasing vulnerability.
  • Infants face a higher risk of pressure injuries due to immature skin, immobility, and medical device use.
  • Validated tools are essential for accurately assessing pressure injury risk in neonates.

Purpose of the Study:

  • To evaluate the psychometric properties of the Italian version of the Neonatal Skin Risk Assessment Scale.
  • Assessing construct validity, internal consistency, and reliability of the scale in the neonatal population.

Main Methods:

  • A cross-sectional descriptive study involving 200 infants across two Italian hospitals.
  • Utilized exploratory and confirmatory factor analysis for construct validity.
  • Assessed internal consistency with McDonald's omega and Cronbach's alpha; reliability with Intraclass Correlation Coefficients (ICC).

Main Results:

  • Confirmatory factor analysis supported a two-factor model: 'duration and intensity of pressure' and 'skin immaturity'.
  • The Italian-Neonatal Skin Risk Assessment Scale demonstrated good internal consistency (omega = 0.86, alpha = 0.86).
  • Excellent intra-observer (ICC=0.99) and inter-observer (ICC=0.98) reliability was observed.

Conclusions:

  • The Italian-Neonatal Skin Risk Assessment Scale is a valid and reliable instrument for assessing pressure injury risk in neonates.
  • This scale is the first newborn-specific tool to incorporate medical device assessment.
  • Its implementation can optimize preventive strategies and risk stratification in neonatal intensive care units.
Abstract